AVEREL: A Randomised Phase 111 Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER-2Positive Locally Recurrent/Metastatic Breast Cancer
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
American Society of Clinical Oncology
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/4315 |
| _version_ | 1848744481400029184 |
|---|---|
| author | Gianni, L. Romieu, G. Lichinister, M. Serrano, S. Mansutti, M. Pivot, X. Mariani, P. Andre, F. Chan, Arlene Lipatov, O. Chan, S. Wardley, A. Greil, R. Moore, N. Prot, S. Pallaud, C. Semiglazov, V. |
| author_facet | Gianni, L. Romieu, G. Lichinister, M. Serrano, S. Mansutti, M. Pivot, X. Mariani, P. Andre, F. Chan, Arlene Lipatov, O. Chan, S. Wardley, A. Greil, R. Moore, N. Prot, S. Pallaud, C. Semiglazov, V. |
| author_sort | Gianni, L. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| first_indexed | 2025-11-14T06:02:09Z |
| format | Journal Article |
| id | curtin-20.500.11937-4315 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T06:02:09Z |
| publishDate | 2013 |
| publisher | American Society of Clinical Oncology |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-43152018-12-14T00:46:04Z AVEREL: A Randomised Phase 111 Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER-2Positive Locally Recurrent/Metastatic Breast Cancer Gianni, L. Romieu, G. Lichinister, M. Serrano, S. Mansutti, M. Pivot, X. Mariani, P. Andre, F. Chan, Arlene Lipatov, O. Chan, S. Wardley, A. Greil, R. Moore, N. Prot, S. Pallaud, C. Semiglazov, V. 2013 Journal Article http://hdl.handle.net/20.500.11937/4315 American Society of Clinical Oncology restricted |
| spellingShingle | Gianni, L. Romieu, G. Lichinister, M. Serrano, S. Mansutti, M. Pivot, X. Mariani, P. Andre, F. Chan, Arlene Lipatov, O. Chan, S. Wardley, A. Greil, R. Moore, N. Prot, S. Pallaud, C. Semiglazov, V. AVEREL: A Randomised Phase 111 Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER-2Positive Locally Recurrent/Metastatic Breast Cancer |
| title | AVEREL: A Randomised Phase 111 Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER-2Positive Locally Recurrent/Metastatic Breast Cancer |
| title_full | AVEREL: A Randomised Phase 111 Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER-2Positive Locally Recurrent/Metastatic Breast Cancer |
| title_fullStr | AVEREL: A Randomised Phase 111 Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER-2Positive Locally Recurrent/Metastatic Breast Cancer |
| title_full_unstemmed | AVEREL: A Randomised Phase 111 Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER-2Positive Locally Recurrent/Metastatic Breast Cancer |
| title_short | AVEREL: A Randomised Phase 111 Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER-2Positive Locally Recurrent/Metastatic Breast Cancer |
| title_sort | averel: a randomised phase 111 trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for her-2positive locally recurrent/metastatic breast cancer |
| url | http://hdl.handle.net/20.500.11937/4315 |